2782 J . Org. Chem., Vol. 61, No. 8, 1996
Rodr´ıguez et al.
degassed benzene, refluxing under argon, a solution of n-Bu3-
SnH (0.11 mL, 2 equiv) and AIBN (20 mg, 20% by weight) in
10 mL of benzene was added via a syringe pump over 5 h.
Once addition had finished, refluxing was kept up for a further
4 h. The benzene was evaporated under vacuum, and the
resulting residue was dissolved in CH3CN. This solution was
washed with hexane, dried over Na2SO4, concentrated, and
chromatographed on silica gel using 1:2 EtOAc/hexane as
eluent. Macrolactam 2a (64 mg, 74%) was obtained as
colorless crystals of mp 187-189 °C (MeOH). IR (KBr) ν 3380,
1H), 7.57 (dt, J ) 7.4, J ) 1 Hz, 1H), 7.49 (dt, J ) 7.5, J ) 1
Hz, 1H), 7.00 (s, 1H), 6.68 (s, 1H), 5.16 (d, J ) 2.4 Hz, 1H),
4.98 (d, J ) 2.4 Hz, 1H), 3.99 (t, J ) 7.4 Hz, 2H), 3.85 (s, 3H),
3.68 (s, 3H), 3.04 (t, J ) 7.4 Hz, 2H). 13C NMR δ 167.5, 148.9,
148.8, 142.0, 136.7, 132.3 (CH), 130.1, 129.9 (CH), 129.6, 123.4
(CH), 120.3 (CH), 115.7 (CH), 114.5, 113.9 (CH), 89.6 (CH2),
56.5 (CH3), 56.4 (CH3), 39.7 (CH2), 34.9 (CH2). MS m/z
(relative intensity) 308 (M+ - Br, 100), 244 (28), 242 (28), 158
(40). Anal. Calcd for C19H18NO3Br, C 58.76, H 4.64, N 3.61.
Found: C 59.10, H 4.63, N 3.61.
2940, 1695, 1505, 1480, 845 cm-1
.
1H NMR δ 6.93 (s, 2H),
7,8,13,13a -Tetr a h yd r o-10,11-d im eth oxy-5H-isoin d olo-
[1,2-b][3]ben za zep in -5-on e (12). To a solution of 11 (0.29
g, 0.75 mmol) and AIBN (58 mg, 20% by weight) in 80 mL of
dry degassed benzene, refluxing under argon, was added n-Bu3-
SnH (0.42 mL, 1.56 mmol) dropwise over 6 min. Once addition
had finished, refluxing was kept up for a further 6 h. The
benzene was evaporated under reduced pressure, and the
resulting residue was taken up in CH3CN. This solution was
washed with hexane, dried over Na2SO4, concentrated, and
chromatographed on silica gel using 1:1 EtOAc/hexane as
eluent. Benzazepine 12 (0.19 g, 81%) was obtained as colorless
crystals of mp 179 °C (EtOAc). IR (KBr) v 3455, 1684, 1518,
6.85 (s, 1H), 6.67 (s, 1H), 6.58 (s, 1H), 5.93 (m, 2H), 5.50 (m,
NH), 4.14 (m, 1H), 3.96 (s, 3H), 3.89 (s, 3H), 3.30 (m, 1H), 2.98
(m, 1H), 2.34 (m, 1H), -0.10 (s, 9H). 13C NMR δ 167.9, 152.2,
149.9, 147.3, 145.7, 145.5, 145.1 (CH), 139.8, 132.7, 132.6,
130.7, 122.3 (CH), 113.3 (CH), 110.9 (CH), 107.2 (CH), 100.8
(CH2), 61.9 (CH3), 55.9 (CH3), 43.7 (CH2), 31.2 (CH2), -0.7
(CH3). MS m/z (relative intensity) 425 (M+, 19), 382 (23), 352
(100), 351 (23), 337 (29), 336 (35), 73 (23). Anal. Calcd for
C23H27NO5Si, C 64.92, H 6.39, N 3.29. Found: C 64.93, H 6.56,
N 3.46.
Len n oxa m in e (1). A suspension of 2a (0.2 g, 0.5 mmol)
and potassium tert-butoxide (11.5 mg, 0.1 mmol) in 4 mL of
dry THF was stirred under argon for 1 h, concentrated under
vacuum, and dissolved in CH2Cl2. This solution was washed
with NH4Cl and brine, dried over Na2SO4, and finally concen-
trated at reduced pressure to give crude 10. IR ν 2954, 2857,
1293 cm-1 1H NMR δ 7.87 (d, J ) 7.5 Hz, 1H), 7.59-7.46 (m,
.
3H), 6.83 (s, 1H), 6.74 (s, 1H), 4.82-4.76 (m, 1H), 4.43 (d, J )
9.8 Hz, 1H), 3.92 (s, 3H), 3.89 (s, 3H), 3.19 (dd, J ) 14.7, 1.6
Hz, 1H), 3.05-2.81 (m, 4H). 13C NMR δ 167.5, 148.0, 147.6,
145.3, 134.1, 132.4, 131.9 (CH), 130.1, 128.8 (CH), 124.2 (CH),
122.5 (CH), 114.1 (CH), 113.9 (CH), 61.8 (CH), 56.5 (CH3), 56.4
(CH3), 42.6 (CH2), 41.9 (CH2), 36.3 (CH2). MS m/z (relative
intensity) 309 (M+, 100), 294 (43), 177 (73). Anal. Calcd for
C19H19NO3, C 73.79, H 6.15, N 4.53. Found: C 73.86, H 6.33,
N 4.58.
1684, 1491, 1429, 1267, 1040, 844 cm-1 1H NMR δ 7.16 (d, J
.
) 8.2 Hz, 1H), 7.12 (d, J ) 8.2 Hz, 1H), 6.65 (s, 2H), 5.95 (m,
2H), 4.64 (m, 2H), 4.09 (s, 3H), 3.91 (s, 3H), 2.98-2.77 (m, 4H),
-0,32 (s, 9H). 13C NMR δ 165.8, 152.8, 147.4, 146.1, 145.5,
137.9, 135.8, 133.1, 125.0, 117.8 (CH), 115.9 (CH), 111.1 (CH),
110.6 (CH), 101.0 (CH2), 62.7 (CH3), 62.5 (CH3), 56.7 (CH), 44.0
(CH), 41.1 CH2), 35.8 (CH2), 0.8 (CH3). MS m/z (relative
intensity) 425 (M+, 67), 424 (100), 410 (30), 394 (18), 352 (13),
336 (12), 264 (27), 149 (11), 76 (56).
N-[2-(6-Br om o-1,3-ben zod ioxol-5-yl)eth yl]-2,3-d ih yd r o-
6,7-d im eth oxy-3-m eth ylen e-1H-isoin d ol-1-on e (3). Potas-
sium carbonate (90 mg, 0.65 mmol) was added to a stirred
solution of 4 (91 mg, 0.18 mmol) in methanol (2 mL), and the
reaction mixture was kept at room temperature for 30 min.
The solid was filtered off, the solvent was removed from the
filtrate under reduced pressure, and the resulting residue was
chromatographed on silica gel using 1:3 EtOAc/hexane as
eluent. Phthalimidine 3 was obtained (74 mg, 95%) as
colorless crystals of mp 149 °C (EtOAc). IR (KBr) ν 3459, 1714,
Tetrabutylammonium fluoride (0.22 g, 0.84 mmol) (1 M
solution in THF, from Acros Chimica) was added to a solution
of this crude product in 3 mL of THF, and this mixture was
stirred at room temperature for 15 min, concentrated, and
dissolved in CH2Cl2. This solution was washed, dried over Na2-
SO4, concentrated under vacuum, and finally chromatographed
on silica gel using 1:2 EtOAc/hexane as eluent. Lennoxamine
(1) (0.1 g, 60%) was obtained as colorless crystals of mp 223-
225 °C (lit.13 225 °C) (MeOH). IR (KBr) ν 2950, 1685, 1430,
1510, 1220 cm-1
.
1H NMR δ 7.35 (d, J ) 8.2 Hz, 1H), 7.13 (d,
J ) 8.2 Hz, 1H); 7.01 (s, 1H), 6.78 (s, 1H), 5.91 (s, 2H), 5.08 (s,
1H), 4.83 (s, 1H), 4.10 (s, 3H), 3.91 (s, 3H), 3.89 (m, 2H), 3.00
(t, J ) 7.7 Hz, 2H). 13C NMR δ 166.1, 154.0, 147.9, 147.7,
141.5, 131.4, 130.6, 123.6, 116.7 (CH); 115.6 (CH), 114.9, 113.1
(CH), 111.0 (CH), 102.1 (CH2), 87.1 (CH2), 62.9 (CH3), 57.1
(CH3), 39.8 (CH2), 35.2 (CH2). MS m/z (relative intensity) 352
(M+ - Br, 100), 218 (62). Anal. Calcd for C20H18BrNO5, C
55.55, H 4.17, N 3.24. Found: C 55.27, H 4.32, N 3.17.
1290, 1270, 1040 cm-1 1H NMR δ 7.17 (d, J ) 8.2 Hz, 1H),
.
7.12 (d, J ) 8.2 Hz, 1H), 6.77 (s, 1H), 6.72 (s, 1H), 5.95 (d, J
) 1.4 Hz, 1H), 5.94 (d, J ) 1.4 Hz, 1H), 4.73 (m, 1H) 4.29 (dd,
J 13a,13R ) 1.3, J 13a,13â ) 10.6 Hz, H13a), 4.09 (s, 3H), 3.91 (s,
3H), 3.09 (dd, J 13a,13R ) 1.3, J 13R,13â ) 14.6 Hz, H13R), 2.81 (dd,
J 13a,13â ) 10.6, J 13R,13â ) 14.6 Hz, H13â), 2.99-2.77 (m, 3H). 13
C
NMR δ 165.2, 152.7, 147.4, 146.4, 146.2, 138.3, 134.9, 131.0,
124.2, 117.1 (CH), 116.4 (CH), 110.4 (2 × CH), 101.1 (CH2),
62.5 (CH3), 60.1 (CH), 56.8 (CH3), 42.7 (CH2), 41.1 (CH2), 35.9
(CH2). MS m/z (relative intesity) 353 (M+, 100), 352, 23), 338
(67), 335 (43), 162 (76), 161 (90), 131 (73). Anal. Calcd for
C20H19NO5, C 67.98, H 5.42, N 3.96. Found: C 68.18; H 5.17,
N 3.88.
Len n oxa m in e (from 3). To a solution of 3 (31 mg, 0.07
mmol) and AIBN (7 mg, 20% by weight) in dry degassed
benzene (12 mL), refluxing under argon, was added n-Bu3SnH
(50 µL, 0.14 mmol) over 2 min. Once addition had finished
refluxing was kept up for 5 h. After the usual workup, the
residue was chromatographed on silica gel using 1:1 EtOAc/
hexane, which gave lennoxamine (15mg, 61%).
N-[2-(2-Br om o-4,5-dim eth oxyph en yl)eth yl]-2,3-dih ydr o-
3-m eth ylen e-1H-isoin d ol-1-on e (11). A mixture of 6-bro-
mohomoveratrylamine (0.97 g, 3.74 mmol) and 2-acetylbenzoic
acid (0.66 g, 4.02 mmol) was heated at 140 °C for 1 h. Once
the mixture had cooled to room temperature, EtOAc (2 mL)
was added and the mixture was then left at 0 °C overnight,
affording a crystalline solid (1.36 g, 94%) which was identified
as 11. Mp 123 °C (EtOAc). IR (KBr) ν 3416, 1720, 1507, 1216
Ack n ow led gm en t. We are grateful to the CICYT
and the Xunta de Galicia for financial support under
projects SAF93-0607 and XUGA 26202A92, respec-
tively. G. Rodr´ıguez and M. M. Cid thanks the Xunta
de Galicia and CICYT, respectively, for fellowships.
cm-1
.
1H NMR δ 7.82 (d, J ) 7.4 Hz, 1H), 7.67 (d, J ) 7.5 Hz,
J O952113K